13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 14 managers

Reported value

$28.8M

Holders

14

+2 new · −1 exited

Holders’ est. mark

$531.5K

Price effect on 5 books still in the name

Largest holder

$13.6M

BANK OF AMERICA CORP /DE/

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BANK OF AMERICA CORP /DE/6.28M$13.6MHeld
MORGAN STANLEY5.58M$12.1MHeld
BARCLAYS PLC936.7K$2.03M$398KAdded$511.5K
Cresset Asset Management, LLC190.5K$413.4K$85.6KAdded$86.1K
TUDOR INVESTMENT CORP ET AL121.7K$264.2KHeld
Leonteq Securities AG95K$206.2K$42.7KAdded$42.8K
FARALLON CAPITAL MANAGEMENT LLC26K$56.4KNew
PVG ASSET MANAGEMENT CORP20.4K$44.2KHeld
Pine Valley Investments Ltd Liability Co11.1K$24K$4.99KCut−$7.5K
Swiss Life Asset Management Ltd11.1K$24KNew
Allworth Financial LP6.52K$14.1KHeld
Essential Partners LLC398$864$179Added$145
IFP Advisors, Inc76$165Held
FNY Investment Advisers, LLC8.75K$18Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.